Loading...

BETA Beta Drugs Ltd Capital Structure Changes Announcement

Bt D

BT

Beta Drugs Ltd

(BETA)

2026 Announcement

Newspaper Publication

Analyst meet update

Regulatory deviation disclo...

Monitoring Agency Report

Audited Results

Earnings Conference Call In...

Equity Investment

Geographic Expansion

Regulation 31(4) disclosures

Price movement clarification

Regulatory compliance

Regulatory clarification

Trading Window Closure

Preferential Allotment

Shareholding and preferenti...

Newspaper Publication

Regulation 32 Deviation Con...

Utilization of Proceeds

Board meeting outcomes

Valuation revision

EGM voting results

Capital Structure Change

Regulatory clarification

Capital structure changes

Asset Acquisition

Asset Acquisition

Equity Acquisition

Regulatory compliance certi...

Trading window closure

Equity acquisition

Trading Window Closure

Analyst Investor Meet

Cancellation of meeting

Analyst/Institutional meet

CCD conversion to equity

Main Board Listing

Main Board Migration

Monitoring agency report

H1 FY26 results

Main Board migration

SEBI LODR Non-Compliance

No Deviation Reported

Link to Recording

Investor Presentation

Financial Results Released

Earnings Call Scheduled

First Indian Approval

Securities Confirmation

AGM Report Submitted

Trading Window Closure

Annual General Meeting

INVIMA Approval

AGM Announcement

Annual General Meeting

Book Closure Notice

Annual General Meeting

Board Meeting Outcome

Cautionary Notice

SEBI Regulation Certificate

Clarification on Financials

Compliance Certificate

Earnings Call Update

Audio Recording Link

Investor Presentation

Monitoring Agency Report

Earnings Call Scheduled

COFEPRIS Approval

Compliance Confirmation

Share Disclosure Filed

Trading Window Closure

Bonus Shares Allotted

Board Meeting Announcement

Record Date Announcement

Bonus Shares Record

Voting Results Submitted

Capital Changes

Capital Increase

Postal Ballot Results

Postal Ballot Notice

Postal Ballot Notice

Director Appointment Clarif...

Board Meeting Outcome

Bonus Share Issue

Bonus Share Announcement

Board Meeting Notice

Trading Window Closure

Quarterly Financial Filing

Governance Filing

SEBI Compliance Certificate

Migration to Main Board

EGM Voting Results

Extraordinary General Meeting

Clarification on Results

EGM Announcement

Board Meeting Update

Board Meeting Notice

Earnings Update

EGM Report Submitted

New Agreements Made

EGM Proceedings

Earnings Call Recording

EGM Notice Update

Investor Presentation

Financial Results Released

Earnings Call Announcement

Earnings Call Scheduled

EGM Notice Update

Forbes Award Earned

EGM Announcement

EGM Announcement

Share Capital Increase

Capital Increase Announced

Board Meeting Notice

Securities Confirmation

AGM Scrutinizer Report

Trading Window Closure

AGM Proceedings

AGM Announcement

Annual General Meeting

AGM Announcement

Book Closure Notice

Board Meeting Outcomes

Confirmation Certificate

Board Meeting Outcome

Earnings Growth

Earnings Call Recording

Financial Results Submission

Earnings Conference Call

Confirmation Certificate

Trading Window Closure

Certificate Confirmation

Forbes Recognition

Earnings conference call

Certificate Announcement

Board Meeting Outcome

External Links:

Data:

Beta Drugs clarifies post-offer ownership percentages for EGM preferential allotment, detailing each allottee’s shares and post-offer stake to address NSE observations.

AI Assistant

Beta Drugs Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.